ENLV EPS Estimates
Enlivex Therapeutics Ltd.
$0.22
+$0.01(+3.99%)
37
Overall
80
Value
9
Tech
23
Quality
Market Cap
$4.29M
Volume
557.16K
52W Range
$0.22 - $27.15
Target Price
$80.00
ENLV EPS estimates: the consensus estimate for Enlivex Therapeutics Ltd.'s current fiscal year is -$1.15 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ENLV EPS Estimates
- EPS estimate, current quarter
- $-0.28
- EPS estimate, next quarter
- $-0.26
- EPS estimate, current year
- $-1.15
- EPS estimate, next year
- $-0.21
- EPS growth, 3-year
- +162.07%
| Fiscal year | EPS |
|---|---|
| 2025 | $27.04 |
| 2024 | $-0.73 |
| 2023 | $-1.69 |
| 2022 | $-1.69 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ENLV | $0.22 | +4.0% | 557.16K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enlivex Therapeutics Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW